International Congress Office

(redirected from ICO)
Also found in: Acronyms, Encyclopedia, Wikipedia.

International Congress Office

An agency of the U.S. Federal Government that encourages organizations to hold their meetings and conventions in the United States. It is based in the U.S. embassy in France.
References in periodicals archive ?
ICO Global Communications (Holdings) Limited is a satellite communications company developing an advanced next-generation hybrid media system, combining both satellite and terrestrial communications capabilities.
Neither ICOS nor Lilly undertake any obligation to update any forward-looking statements.
1 Cialis[R] is a registered trademark of Lilly ICOS LLC.
ICOS also announced that its board has set a new record date, December 26, 2006, for shareholders entitled to vote on the merger.
ICOS will continue to report its financial statements for the fourth quarter 2006 and the full year 2006 according to USGAAP.
Lilly's offer is very attractive for our shareholders and reflects the tremendous value ICOS has created," said Paul Clark, ICOS chairman, president and chief executive officer.
ICOS is headquartered in Leuven, Belgium and has R&D centers in Belgium, Germany and Hong Kong and sales and support offices in Japan, the USA, Singapore, Hong Kong and Korea and production facilities in Belgium, Hong Kong and China.
Webcast replay, available through August 10, 2006, on the ICOS Web site at www.
This product, the outcome of a five-year new product program at ICOS and the company's most sizeable investment in new product development ever, illustrates ICOS' abiding commitment to research and development as a means of sustaining its technological leadership.
We are very excited about the prospect of bringing Cialis Once-A-Day to the market in North America and Europe," stated Paul Clark, ICOS Chairman and CEO.
Nasdaq: DYAX) announced today that it has granted a non-exclusive license to its proprietary phage display libraries to ICOS Corporation (Nasdaq: ICOS) for the discovery and development of therapeutic antibodies.
BOTHELL, Wash -- ICOS Corporation (Nasdaq:ICOS) will announce its 2006 first quarter financial results on Thursday, May 4, 2006, after the market close.